Lindsay B Harrison

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi request reprint Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs
    Lindsay B Harrison
    Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
    J Investig Med 61:40-4. 2013
  2. doi request reprint Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial
    Lindsay B Harrison
    From the Divisions of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Biostatistics, Department of Clinical Sciences, Mineral Metabolism, Department of Internal Medicine, and Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
    J Investig Med 62:676-86. 2014
  3. pmc β-cell function preservation after 3.5 years of intensive diabetes therapy
    Lindsay B Harrison
    Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Diabetes Care 35:1406-12. 2012

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs
    Lindsay B Harrison
    Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA
    J Investig Med 61:40-4. 2013
    ..To observe the efficacy and safety of glucagonlike peptide-1 (GLP-1) analogs in type 1 diabetes in a real-life medical practice setting...
  2. doi request reprint Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial
    Lindsay B Harrison
    From the Divisions of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, Biostatistics, Department of Clinical Sciences, Mineral Metabolism, Department of Internal Medicine, and Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX
    J Investig Med 62:676-86. 2014
    ..This study aimed to assess the efficacy of early intensive diabetes therapy with either insulin plus metformin (INS) or triple oral therapy (TOT) with metformin, glyburide, and pioglitazone on glycemic control and A-cell function...
  3. pmc β-cell function preservation after 3.5 years of intensive diabetes therapy
    Lindsay B Harrison
    Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Diabetes Care 35:1406-12. 2012
    ..To assess β-cell function preservation after 3.5 years of intensive therapy with insulin plus metformin (INS group) versus triple oral therapy (TOT group) with metformin, glyburide, and pioglitazone...